Auro Laboratories
Auro Laboratories Share Price Chart
Auro Laboratories last traded at ₹228.95 (2026-10-13). Over the past month the stock moved -10.9%, three months the stock moved -14.3%, year the stock moved -4.4%. Its closing range over 52 weeks is ₹183.50 – ₹291.95, with the latest close 21.6% below the high.
Closing prices up to 2026-10-13.
About Auro Laboratories
Incorporated in 1989, Auro Laboratories Ltd is in the business of Bulk Drugs[1]
Business Overview:[1][2] Auro Laboratories Limited manufactures generic APIs, primarily Metformin Hydrochloride for type 2 diabetes. It operates an approved manufacturing facility with Indian regulatory approvals and European registrations, has expanded production capacity, and also undertakes toll and custom manufacturing of APIs and intermediates on a contract basis.
Fundamentals
Quarterly Results
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Sep 2025 | 8.84 | 2.35 | 26.58 | 0.72 | 1.16 |
| Jun 2025 | 2.77 | 0.03 | 1.08 | -0.11 | -0.18 |
| Sep 2024 | 3.10 | 0.72 | 23.23 | 0.36 | 0.58 |
Annual Financials
In the latest year (Mar 2025), Auro Laboratories reported sales of ₹19.40 crore (-63.8%) and net profit of ₹1.84 crore (-76.4%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2025 | 19.40 | 3.40 | 17.53 | 1.84 | 2.95 |
| Mar 2024 | 53.64 | 10.68 | 19.91 | 7.79 | 12.50 |
| Mar 2023 | 52.89 | 4.39 | 8.30 | 2.44 | 3.91 |
| Mar 2022 | 50.87 | 4.63 | 9.10 | 2.84 | 4.56 |
| Mar 2021 | 54.25 | 11.24 | 20.72 | 7.18 | 11.52 |
| Mar 2020 | 43.79 | 6.28 | 14.34 | 4.05 | 6.50 |
| Mar 2019 | 46.82 | 6.99 | 14.93 | 4.40 | 7.06 |
| Mar 2018 | 40.79 | 6.36 | 15.59 | 3.53 | 5.66 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +15.0% | +14.8% | -6.5% | +23.9% | -6.2% | +4.0% | +1.4% | -63.8% |
| Operating profit growth | +43.2% | +9.9% | -10.2% | +79.0% | -58.8% | -5.2% | +143.3% | -68.2% |
| Net profit growth | +330.5% | +24.6% | -8.0% | +77.3% | -60.4% | -14.1% | +219.3% | -76.4% |
| EPS growth | +328.8% | +24.7% | -7.9% | +77.2% | -60.4% | -14.3% | +219.7% | -76.4% |
| OPM % | 15.6% | 14.9% | 14.3% | 20.7% | 9.1% | 8.3% | 19.9% | 17.5% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Auro Laboratories.
Get Free AI Stock Analysis FREE →Latest News
-
Auro Laboratories Limited schedules 37th AGM on August 11, 2026 - scanx.trade
-
Auro Laboratories zooms on getting WHO-GMP certificate for Tarapur API facility
-
Auro Laboratories gets WHO-GMP certificate for Tarapur API manufacturing facility
Frequently Asked Questions
What is the share price of Auro Laboratories today?
Auro Laboratories shares were last quoted at ₹228.95 (-3.2% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Auro Laboratories?
Auro Laboratories has a price-to-earnings (P/E) ratio of 31.34 and a price-to-book (P/B) ratio of 3.10. The industry P/E is 52.82.
What is the 52-week high and low of Auro Laboratories?
The 52-week high of Auro Laboratories is ₹317.00 and the 52-week low is ₹159.00.
What is the market cap of Auro Laboratories?
The market capitalisation of Auro Laboratories is about ₹146.68 crore.
What is the promoter holding in Auro Laboratories?
Promoters hold about 52.40% of Auro Laboratories.
Which sector does Auro Laboratories belong to?
Auro Laboratories belongs to the Pharmaceuticals & Drugs sector.